ABSTRACT
BACKGROUND: The reconstruction of surgical defects in high-tension anatomical regions is challenging due to the ischemia and subsequent necrosis associated with tension closure. Research on new flaps capable of closing these defects exerting less tension would be a tremendous advancement in dermatological surgery. PATIENTS AND METHODS: We conducted a multicenter, retrospective study that used 2 new flaps-the bishop and the sigma ones-to repair surgical defects in high-tension regions such as the scalp, lower extremities, and the nasal pyramid. The bishop flap was used in 9 patients, 5 of whom exhibited their lesion in the nasal pyramid, 2 in the legs and another 2 in the scalp. The sigma flap was used in 6 patients, 5 of whom exhibited scalp lesions and 1 leg lesion. RESULTS: Uneventful and excellent results were obtained in all 15 patients due to infection, dehiscence, or necrosis. CONCLUSIONS: Both the bishop and the sigma flaps are a good alternative to repair surgical defects in high-tension regions such as the scalp, lower extremities, or the nasal pyramid.
ABSTRACT
El propranolol, un betabloqueante no selectivo, sigue siendo la primera línea de tratamiento para el hemangioma infantil problemático. Sin embargo, aunque poco frecuente, un subgrupo de pacientes experimenta efectos secundarios indeseables, lo que despierta el interés sobre otros betabloqueantes selectivos. Presentamos una amplia serie de casos de 46 lactantes tratados con éxito con atenolol, un bloqueante selectivo beta-1
Propranolol, a non-selective beta-blocker, remains the first line of treatment for problematic infantile hemangioma. However, although rarely, a subset of patients experience undesirable side effects, raising interest in other selective beta-blockers. We present a large case series of 46 infants treated successfully with oral atenolol, a selective beta-1 blocker
Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Atenolol/administration & dosage , Hemangioma/drug therapy , Atenolol/antagonists & inhibitors , Adrenergic beta-1 Receptor Antagonists , Drug-Related Side Effects and Adverse Reactions/complications , Diarrhea/complicationsABSTRACT
Propranolol, a non-selective beta-blocker, remains the first line of treatment for problematic infantile hemangioma. However, although rarely, a subset of patients experience undesirable side effects, raising interest in other selective beta-blockers. We present a large case series of 46 infants treated successfully with oral atenolol, a selective beta-1 blocker.
Subject(s)
Adrenergic beta-1 Receptor Antagonists/administration & dosage , Atenolol/administration & dosage , Hemangioma, Capillary/drug therapy , Skin Neoplasms/drug therapy , Administration, Oral , Female , Humans , Infant , MaleABSTRACT
No disponible
Subject(s)
Humans , Male , Child , Skin Diseases, Viral/diagnosis , Xanthogranuloma, Juvenile/diagnosis , Hand/pathology , Xanthogranuloma, Juvenile/pathology , Biopsy , Dermoscopy , Diagnosis, DifferentialABSTRACT
No disponible
Subject(s)
Humans , Female , Infant, Newborn , Hemangioma/pathology , Skin Neoplasms/pathology , Meningomyelocele/complications , Comorbidity , Diaper Rash/diagnosis , Fissure in Ano/diagnosisABSTRACT
No disponible
